Regulus Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2020
Period Ending	Aug '25 Aug 5, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2020
Market Capitalization	148	204	263	150	688	-	Upgrade
Market Cap Growth	-45.25%	-22.51%	75.97%	-78.26%	-	-	Upgrade
Enterprise Value	76	137	148	21	522	-	Upgrade
Last Close Price	2.17	2.99	3.22	1.88	8.91	-	Upgrade
Forward PE	-	138.54	-	-	-	-	Upgrade
PS Ratio	1.50	2.12	3.38	2.15	14.26	-	Upgrade
PB Ratio	2.45	3.41	2.43	1.26	4.47	-	Upgrade
P/TBV Ratio	2.46	3.42	2.44	1.26	4.47	-	Upgrade
P/FCF Ratio	14.71	20.88	-	-	-	-	Upgrade
P/OCF Ratio	14.52	20.28	-	-	-	-	Upgrade
EV/Sales Ratio	0.77	1.42	1.89	0.31	10.81	-	Upgrade
EV/FCF Ratio	7.61	14.00	-	-	-	-	Upgrade
Debt / Equity Ratio	0.04	0.04	0.01	0.02	0.01	0.26	Upgrade
Debt / FCF Ratio	0.24	0.26	-	-	-	0.58	Upgrade
Asset Turnover	0.87	0.84	0.59	0.44	0.53	2.26	Upgrade
Quick Ratio	2.98	2.94	5.91	7.10	12.22	1.60	Upgrade
Current Ratio	3.15	3.16	6.19	7.25	12.50	1.68	Upgrade
Return on Equity (ROE)	2.04%	-0.38%	-11.52%	-34.78%	-41.56%	-37.27%	Upgrade
Return on Assets (ROA)	-0.86%	-1.92%	-6.60%	-16.43%	-20.91%	-9.87%	Upgrade
Return on Capital (ROIC)	-1.11%	-2.42%	-7.67%	-18.22%	-23.52%	-18.21%	Upgrade
Earnings Yield	1.20%	-0.17%	-4.91%	-32.95%	-4.85%	-	Upgrade
FCF Yield	6.80%	4.79%	-2.73%	-24.50%	-3.46%	-	Upgrade
Buyback Yield / Dilution	12.26%	8.07%	-2.64%	-20.88%	-57.35%	-189.18%	Upgrade

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.